Skip to content

Patients Doctors Investors Gliovac News About Contact us

Patients Doctors Investors Gliovac News About Contact us

News / Investors

10 Jun 2022

ERC Belgium balance sheet for the financial year ending 31 Dec 2021

Download the ERC Belgium balace sheet for the financial year ending 31 Dec 2021.

ERC develops Gliovac (ERC1671/sitoiganap), a cell-based immunotherapy for high-grade brain tumours.

European headquarters

Scientific Park Crealys
Rue Jean Sonet 10
5032 Gembloux Isnes
Belgium

+32 81 72 86 10 ceo@ercbelgium.eu

Offices

Netherlands USA New York USA California Canada Australia Press Contact

Company

Our team Milestones News Publications Contact

© 2001–2026 ERC SA. All rights reserved.Cookie and Privacy Policy Terms & Conditions

This site uses cookies. Read our Cookie and Privacy Policy.